Blueprint Medicines Competitors and Similar CompaniesClear all

Blueprint Medicines's competitors and similar companies include Repare Therapeutics and Ohm Oncology.
Blueprint Medicines
Blueprint Medicines
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
Ohm Oncology
Ohm Oncology
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
Founding Date
Founding Date
2011
Founding Date
2016
Founding Date
2015
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Amsterdam, NL
Lugano, CH
Zug, CH
Locations
Montréal, CA HQ
Cambridge, US
Locations
Austin, US HQ
Employees
Employees
6552% increase
Employees
1791% decrease
Employees
167% decrease
Valuation ($)
Valuation ($)
6.6 b
Valuation ($)
151.5 m
Valuation ($)
N/A
Twitter followers
Twitter followers
2.8 k
Twitter followers
1 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$249.4m (FY, 2023)
Revenue (est.)
$51.1m (FY, 2023)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$8.5m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$240.8m (FY, 2023)
Gross profit
$51.1m (FY, 2023)
Gross profit
N/A
Net income
Net income
($507m) (FY, 2023)
Net income
($93.8m) (FY, 2023)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 1.7b
Total funding raised
$ 150.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Repare Therapeutics
HQ
Montréal, CA
Employees
179↓ 1% decrease

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.

View company
Ohm Oncology
HQ
Austin, US
Employees
1

Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.

View company